Abstract:Norovirus are a major cause of acute gastroenteritis worldwide. Diarrheal disease is now the fourth common cause of mortality children under the age of 5 years but remain the 2nd most cause of morbidity. NoV are associated with 18% diarrheal diseases worldwide where rotavirus vaccinations has been successfully introduced. NoV has become major cause of gastroenteritis in children. NoV belong to family caliciviridae. They are non-enveloped, single stranded positive sense RNA Viruses. The genome consists of 3 Open reading frames, ORF-1 codes for non-structural protein, ORF-2 codes for major capsid protein VP1 and ORF-3 for minor capsid protein VP2. Based on sequence difference of the capsid gene (VP1), NoV have been classified in to seven genogroup GI-GVII with over 30 genotypes. Genogroups I, II, IV are associated with human infection. Despite this extensive diversity a single genotype GII.4 has been alone to be the more prevalent. Basic epidemiological disease burden data are generated from developing countries. NoV are considered fast evolving viruses and present an extensive diversity that is driven by acquisition of point mutations and recombinations. Immunity is strain or genotype specific with little or no protection conferred across genogroups. Majority of outbreaks and sporadic norovirus cases worldwide are associated with a single genotype, GII.4 which was responsible for 62% of reported NoV outbreaks in 5 continents from 2001 to 2007. GII.4 variants have been reported as major cause of global gastroenteritis pandemics starting in 1995 frequent emergence of novel GII.4 variants is known to be due to rapid evolution and antigenic variation in response to herd immunity. Novel GII.4 variants appear almost every 2 years. Recent GII.4 variant reported include Lordsdale 1996, Farmington Hills 2002, Hunter 2004, Yerseke 2006a, Den Haag 2006b, Apeldoon 2007, New Orleans 2009,most recently Sydney 2012. Detailed molecular epidemiologic investigation of NoV is associated for understanding the genetic diversity of NoV strain and emergence of novel NoV variants. However, reports have revealed that not all individuals develop symptoms and a significant proportion remains asymptomatic after NoV infections.

The Epidemiologic and Clinical Importance of Norovirus Infection

Noroviruses: epidemiology, immunity and prospects for prevention

Norovirus: Facts and Reflections from Past, Present, and Future

The epidemiology of published norovirus outbreaks: a review of risk factors associated with attack rate and genogroup

The Norovirus Epidemiologic Triad: Predictors of Severe Outcomes in US Norovirus Outbreaks, 2009–2016

Worldwide molecular epidemiology of norovirus infection

Noroviruses: Evolutionary Dynamics, Epidemiology, Pathogenesis, and Vaccine Advances—A Comprehensive Review

A narrative review of norovirus epidemiology, biology, and challenges to vaccine development

Advances in Norovirus Biology

Norovirus diagnostics: options, applications and interpretations

Norovirus and Foodborne Disease, United States, 1991–2000

The Dynamics of Norovirus Outbreak Epidemics: Recent Insights

Norovirus: a challenging pathogen

Norovirus immunology: Of mice and mechanisms

Outbreak Management and Implications of a Nosocomial Norovirus Outbreak

The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control

Norovirus Structure and Classification

Norovirus Surveillance: An Epidemiological Perspective

Infection control for norovirus

Reevaluation of epidemiological criteria for identifying outbreaks of acute gastroenteritis due to norovirus: United States, 1998-2000

A Bibliometric Analysis of the Literature on Norovirus Disease from 1991–2021